Filing Flows › Mimedx Group (MDXG) › How it makes money
How Mimedx Group (MDXG) makes money
Mimedx Group (MDXG) made $62.3M of revenue in the third quarter 2026 (Q3 2026), -45% from a year earlier. Surgical brought in $40.0M (64%); Wound brought in $22.3M (36%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Surgical | $40.0M | 64.2% | +2% | +9% |
| Wound | $22.3M | 35.8% | -11% | -71% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $62.3M | 100.0% |
| Operating cash flow | $3.9M | 6.3% |
| Free cash flow | $3.8M | 6.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $62.3M | -45% |
| Q2 2026 | $64.4M | -35% |
| Q1 2026 | $59.0M | -33% |
| Q4 2025 | $118M | +27% |
| Q3 2025 | $114M | +35% |
| Q2 2025 | $98.6M | +13% |
| Q1 2025 | $88.2M | +4% |
From Mimedx Group's 10-Q filed Oct 28, 2026 (on EDGAR).
Questions
How does Mimedx Group make money?
Mimedx Group (MDXG) made $62.3M of revenue in the third quarter 2026 (Q3 2026), -45% from a year earlier. Surgical brought in $40.0M (64%); Wound brought in $22.3M (36%).
What is Mimedx Group's biggest business?
Surgical: $40.0M in the third quarter 2026, 64% of revenue, +9% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.